From: Surgical results of pelvic exenteration in the treatment of gynecologic cancer
Overall | APE | PPE | TPE | P-value | |
---|---|---|---|---|---|
Number of patients | 28 | 7 (25%) | 7 (25%) | 14 (50%) | – |
Mean age (range), yr | 55 (24 to 78) | 58 (43 to 78) | 56 (36 to 73) | 52 (34 to 73) | (0.725) |
Site | |||||
Cervical | 18 | 6 | 3 | 9 | (0.246) |
Uterine | 3 | 1 | 0 | 2 | – |
Ovarian | 6 | 0 | 4 | 2 | – |
Vaginal | 1 | 0 | 0 | 1 | – |
Clinical stage (cervical cancer) | |||||
I | 3 | 0 | 1 | 2 | (0.246) |
II | 5 | 2 | 1 | 2 | – |
III | 10 | 4 | 1 | 5 | – |
Previous radiotherapyb, n (%) | 17 (61%) | 7 (100%) | 2 (28%) | 8 (57%) | (0.021) |